Journal of Biotechnology · 2009 · 17 citations · 17 references
PharmacyOncologyPharmacologyImmunotherapyMolecular OncologyMonoclonal AntibodiesAntibody CharacterizationCancer ImmunotherapyMonoclonal Antibody TherapyTargeted Cancer TherapyTherapeutic Antibody DevelopmentTherapeutic Monoclonal AntibodiesCetuximab TherapyEgfr InhibitionEpidermal Growth Factor Receptor Targeting LigandsMonoclonal Antibodies In CancerMonoclonal Antibodies In OncologyPeptide EpitopesTumor Growth Rate
17
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
Matthew C. Franklin, Kendall D. Carey, F.F. Vajdos et al. · Cancer Cell · 2004 · 1.1K citations · Full text
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
Shiqing Li, Karl R. Schmitz, Philip D. Jeffrey et al. · Cancer Cell · 2005 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +13
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
J. Denry Sato, Tomoyuki Kawamoto, Anh D. Le et al. · PubMed · 1983 · 458 citations
Gordon N. Gill, Tomoyuki Kawamoto, Claude Cochet et al. · Journal of Biological Chemistry · 1984 · 458 citations · Full text